-
Our experts are looking forward to discussing with you new perspective on
#vascularintegrity at the Weimar#SepsisUpdate. Visit us at booth 29#sphingotec#TheBiomarkerCompany#Diagnostics#adrenomed#AcuteCare#bio-ADM®#acuteheartfailure#septicshock#AKI#WorldSepsisDaypic.twitter.com/Cpou6X9X1P
-
#Sepsis is killing more people than cancer. Learn more about Adrenomed’s lead product candidate: a first-in-class antibody counteracting vascular leakage and shock to rescue#vascularintegrity in sepsis. http://www.adrenomed.com https://twitter.com/bbchealth/status/1217856840387698688 … -
@Adrenomed develops a new strategy against#sepsis: tackle the disease heterogeneity through intervening downstream in the pathological process by targeting#vascularintegrity. Read more about the science behind it and the company’s mission in@BioCentury https://bit.ly/354eBAj pic.twitter.com/DRSogoUJfj
-
Today, our CBO, Dr. Hein, will give a
#company presentation at#BIOEurope, 11:15 AM, Level 1/Hall B1/Room 6
. Join and discover how #Adrenomed tackles#septicshock by restoring#vascularintegrity with its first-in-class#Adrecizumab https://bit.ly/2BuxeAS pic.twitter.com/cSXeP8Dw2t
-
Thank you for joining our experts at
#SepsisUpdate in Weimar and for the shared knowledge around enhancing#vascularintegrity and going beyond standard of care. http://ow.ly/ZgL350wcFtE#sepsis#endothelialdysfunction#sphingotec#TheBiomarkerCompany#diagnostics#biomarkerpic.twitter.com/BZAHrBXuWl
-
In less than a week,
@adrenomed will be heading off to#Hamburg to attend#BIOEurope, 11-13.11.! Join the company presentation to learn about our program to rescue#vascularintegrity in#sepsis! See you there! https://bit.ly/2ozSdPH@EBDgrouppic.twitter.com/lsywryxVDW
-
Only one day until the
#WorldSepsisDay. Join our symposium at the#SepsisUpdate in#Weimar on September 13: "Beyond Standard of Care – New Perspectives on Vascular Integrity in Shock”@sphingotec@adrenomed#Diagnostics#biomarkers#bioADM®#vascularintegrity#septicshockpic.twitter.com/7zicypVp6A
-
#Adrenomed announces the successful completion of enrollment in the 300-patient PoC Phase II trial, AdrenOSS-2. “By restoring#vascularintegrity, we aim to provide#ICU physicians with a new therapy for#sepsis patients,” said Dr. Andreas Bergmann, CSO https://bit.ly/2lJiKcd pic.twitter.com/PoB86Q66Oc
-
Today, Dr. Peter Pickkers
@Radboud_Uni will give a talk “#Adrenomedullin in#sepsis, effect of the non-inhibitory antibody#Adrecizumab”@ESICM#lives2019. This drug candidate developed by@Adrenomed has a novel MoA to restore#vascularintegrity https://bit.ly/2kH2dEY pic.twitter.com/o2PMtuvYZ7
-
Scientists at
@dzhk_germany are studying whether a monoclonal antibody restoring#vascularintegrity is safe and has positive effects on organ functions of patients with#cardiogenicshock.@adrenomed#CardiovascularResearch https://healthcare-in-europe.com/en/news/first-use-of-vasoprotective-antibody-in-cardiogenic-shock.html …pic.twitter.com/iYVEL5OI16
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.